Drugs Made In America Acquisition (DMIIR) Accumulated Expenses (2025)
Drugs Made In America Acquisition's (DMIIR) quarterly Accumulated Expenses came in at $88343.0 in Q4 2025, up 1411.95% on a QoQ basis from $5843.0 in Q3 2025.
Drugs Made In America Acquisition (DMIIR) Accumulated Expenses (2025) Analysis & Trends
Drugs Made In America Acquisition (DMIIR) has 1 years of Accumulated Expenses data on file, last reported at $88343.0 in Q4 2025.
- On a quarterly basis, Accumulated Expenses changed N/A year-over-year to $88343.0 in Q4 2025; TTM through Dec 2025 was $88343.0, a N/A change from a year earlier, with the FY2025 full-year figure at $88343.0, changed N/A from the prior year.
- Accumulated Expenses for Q4 2025 stood at $88343.0, up from $5843.0 in the prior quarter.
- Over the last five years, Accumulated Expenses for DMIIR reached as high as $88343.0 in Q4 2025 and fell as low as $5843.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | EQV Ventures Acquisition | 480.75 Mn | 480.75 Mn | - |
| 2 | Agriculture & Natural Solutions Acquisition | 393.29 Mn | 393.29 Mn | - |
| 3 | Berto Acquisition | 314.56 Mn | 314.35 Mn | - |
| 4 | GP-Act III Acquisition | 313.66 Mn | 313.66 Mn | - |
| 5 | Centurion Acquisition | 311.65 Mn | 311.65 Mn | - |
| 6 | Republic Digital Acquisition | 310.50 Mn | 309.63 Mn | - |
| 7 | Siddhi Acquisition Corp (Cayman Islands) | 288.97 Mn | 288.97 Mn | - |
| 8 | K&F Growth Acquisition | 283.42 Mn | 283.42 Mn | - |
| 9 | Bold Eagle Acquisition | 275.29 Mn | 275.29 Mn | - |
| 10 | Drugs Made In America Acquisition | - | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 88,343.00 |
| Sep 30, 2025 | 5,843.00 |